Harbor Regulations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In connection with the November 2023 Health Care Compliance Association's (HCCA) Healthcare Enforcement Compliance Conference, and with acknowledgment...

請使用下列任何一種瀏覽器瀏覽以達至最佳的用戶體驗：Google Chrome、Mozilla Firefox、Internet Explorer、Microsoft Edge 或Safari。 為避免使用網頁時發生問題，請確保你的網頁瀏覽器已更新至最新版本。 ") $(".mobile-search-page .hot-words-block-items").append(" " + result[i] + "") } } }); $("#"+hotWordsId).on("focus","input",function(){ let hotWordId=$(this).parent().attr("id"); let value = $(this).val(); if(value == ""){ $(".hot-words-block")....

A recent Fourth Circuit decision, United States v. Mallory (988 F.3d 730), upheld damages and penalties for more than $100 million for violations of the Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) (the “AKS”) and the False Claims Act (31 U.S.C. § 3729) by a blood testing laboratory and its contracted sales agents. The Court held that commission payments made by the laboratory to its sales agents (sales companies that, in turn, hired and contracted salespeople to sell the laboratory blood tests), which were based on the percentage of revenue the sales agents generated for the labora...

Tuesday, April 20, 2021 A recent Fourth Circuit decision,  United States v. Mallory (988 F.3d 730), upheld damages and penalties for more than $100 million for violations of the Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) (the “AKS”) and the False Claims Act (31 U.S.C. § 3729) by a blood testing laboratory and its contracted sales agents.  The Court held that commission payments made by the laboratory to its sales agents (sales companies that, in turn, hired and contracted salespeople to sell the laboratory blood tests), which were based on the percentage of revenue the...